Thus, the IL-33/ST2 interaction is associated with decreased frequencies of NK cells in the tumor environment and decreased cytotoxic activity, indicating that IL33/ST2 plays a suppressive role in NK cell functions during tumor development. The gene discussed is IL33; the disease is neoplasm.